The headline index of 52.7 (vs. 52.5 expected and 52.4 previously) marks the third consecutive month of expansion, but the report’s internal details are cooling market enthusiasm.
-
Inflationary Shock (Prices Paid: 78.3 vs. 73.0): This is the report’s critical takeaway. Input costs are rising at their fastest pace since mid-2022. Such intense price pressure (commodities, tariffs) is a major "red flag" for the Fed, pushing back the timeline for potential rate cuts, altough the market is pricing only 20-30% probability of interest hike this year.
-
Sustained Recovery (Headline PMI: 52.7): Manufacturing has definitively moved past the 2025 slump. The U.S. economy's resilience provides the Fed with more room to maintain its restrictive monetary policy.
-
Waning Demand Momentum (New Orders: 53.5): While orders are still growing, the pace has decelerated compared to February (55.8). This suggests that the initial wave of New Year optimism and restocking is beginning to fade.
-
Weak Labor Demand (Employment: 48.7): Despite rising production, the sector remains in contraction territory regarding hiring (reading below 50). Firms may be pivoting toward automation or trimming labor costs to offset soaring material prices.
This report is decidedly hawkish, especially looking from the inflation side. The combination of robust growth and a massive spike in input costs should support the US Dollar and Treasury yields while weighing on tech valuations (US100). The "higher for longer" interest rate scenario has just become even more plausible.
Of course, EURUSD is responding to the hope that the conflict in the Middle East will end soon. Decreasing risk in negative for the US dollar and the EURUSD is once again above 1.16, breaking above the downward trend line.
BREAKING: U.S. retail sales above expectations! EUR/USD is gaining!
BREAKING: US ADP report higher than expected, USDIDX reacts
BREAKING: Eurozone PMI stronger than expected 📈 EURUSD gains
Economic calendar: ISM and ADP data ahead 🔎
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.